NPCENeuroPace, Inc.
$12.37+16% 1Y
$12.37
$9.4052 weeks$19.29
NPCE in its own filings
Nothing in NPCE's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
88
Events found in the filings · across 353 filings · the record starts in 2021
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 11, 2026
Most recent filing · Form 10-Q
- Record starts
- Feb 25, 2021
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 3, 2026
- SEC comment-letter activity9 occurrences
- 2021-04-21
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 11, 2026NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance.Earnings release · press release
- Jul 28, 2026NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized.Regulation FD disclosure · press release
- May 12, 2026NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance.Earnings release · press release
- Mar 3, 2026NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook.Earnings release · press release
- Nov 4, 2025NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…